Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiac resynchronisation therapy for heart failure.

M W H Behan1, C A Rinaldi

  • 1Cardiothoracic Department, St Thomas' Hospital, Guy's and St Thomas' NHS Trust, London SE1 7EH, UK.

International Journal of Clinical Practice
|August 31, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Left ventricular endocardial pacing is less arrhythmogenic than conventional epicardial pacing when pacing in proximity to scar.

Heart rhythm·2020
Same author

A rule-based method for predicting the electrical activation of the heart with cardiac resynchronization therapy from non-invasive clinical data.

Medical image analysis·2019
Same author

Differential effect with septal and apical RV pacing on ventricular activation in patients with left bundle branch block assessed by non-invasive electrical imaging and in silico modelling.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2019
Same author

Economic impact of introducing TYRX amongst patients with heart failure and reduced ejection fraction undergoing implanted cardiac device procedures: a retrospective model based cost analysis.

Journal of medical economics·2019
Same author

Left ventricular endocardial pacing for the critically ill.

Intensive care medicine·2018
Same author

Is the rapidly paced pig the optimal model for endocardial cardiac resynchronization therapy?

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2017

Cardiac resynchronisation therapy (CRT) improves heart function and survival in chronic heart failure patients. Combining CRT with an implantable cardioverter defibrillator (ICD) may further reduce mortality, making it a valuable treatment option.

Area of Science:

  • Cardiology
  • Medical Devices

Background:

  • Chronic heart failure (CHF) with left ventricular systolic dysfunction and prolonged QRS duration impacts patient outcomes.
  • Cardiac resynchronisation therapy (CRT) is an established treatment for select CHF patients.

Observation:

  • Recent studies indicate CRT reduces mortality in CHF patients.
  • Combining CRT with an implantable cardioverter defibrillator (ICD) may offer additional mortality benefits.
  • CRT is generally well-tolerated and bypasses compliance issues.

Findings:

  • CRT improves left ventricular function and reduces symptoms in CHF patients.
  • Evidence suggests CRT significantly reduces mortality, with potential for greater reduction when combined with an ICD.
  • Identifying optimal candidates for CRT is crucial for maximizing benefits and has health economic implications.

Related Experiment Videos

Implications:

  • CRT should be strongly considered for all eligible CHF patients due to its tolerability and efficacy.
  • Further research is needed to identify patient subgroups who will benefit most from CRT.
  • The use of an intra-aortic balloon pump as a bridge to CRT in end-stage heart failure is a viable therapeutic strategy.